TAP-patients With Robotic Assisted Lap Prostatectomy
| Status: | Completed |
|---|---|
| Conditions: | Chronic Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 5/27/2013 |
| Start Date: | March 2012 |
| End Date: | May 2012 |
| Contact: | Jocelyn Wise |
| Email: | jocelyn.wise@steward.org |
Evaluation of the Safety and Efficacy of EXPAREL When Administered by Infiltration Into the Transversus Abdominis Plane (TAP) for Prolonged Postsurgical Analgesia in Subjects Undergoing Robot-assisted Laparoscopic Prostatectomy
The study of the analgesic affect when infiltrated into the TAP for men undergoing
prostatectomy.
Inclusion Criteria:
- male subjects, aged 18-75
- ASA physical status 1-3
- Undergoing robot-assisted laparoscopic prostatectomy performed by a single surgeon
(Ingolf Tuerk, MD)
- Subjects must be physically and mentally able to participate in the study and
complete all study assessments.
- Subjects must be able to give fully informed consent to participate in this study
after demonstrating a good understanding of the risks and benefits of the TAP
infiltration.
Exclusion Criteria:
- Demonstrated hypersensitivity or idiosyncratic reactions to amide-type local
anesthetics.
- Inability to tolerate oxycodone with acetaminophen (e.g. Percocet)
- Any subject whose anatomy or surgical procedure in the opinion of the Investigator
might preclude the potential successful performance of a TAP.
- Any subject who in the opinion of the Investigator might be harmed or be a poor
candidate for participation in the study.
- Subjects who have received any investigational drug within 30 days prior to study
drug administration or planned administration of another investigational product or
procedure during their participation in this study.
We found this trial at
1
site
Click here to add this to my saved trials
